Gut Microbiota Profiling of Lebanese Patients with Ulcerative Colitis and Healthy Controls: A Pilot Study
Download from source ↗Dataset overview
Gut microbiota profiling in Lebanese ulcerative colitis patients and healthy controls from a pilot study.
Abstract
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon, associated with gut microbiota dysbiosis. While global studies have explored this link, region-specific microbial profiles remain underreported. This pilot study aimed to characterize and compare, for the first time, the gut microbiota of Lebanese UC patients and healthy controls using 16 S rRNA gene sequencing (V3-V4 region). Fecal samples from 11 UC patients and 11 healthy individuals were analyzed. Alpha and beta diversity metrics were computed, and gut microbial composition was assessed across taxonomic levels. Statistical comparisons used Mann-Whitney and Fisher's exact tests. UC patients showed significantly reduced microbial diversity based on Faith's Phylogenetic Diversity and Shannon index (p < 0.05), though evenness was unaffected. Beta diversity also revealed significant group-level dissimilarities (p < 0.05). At the phylum level, Bacteroidota was elevated in UC, while Bacillota and Actinomycetota were reduced. Genera such as Ruminococcus, Bacteroides, and Coprococcus were depleted in UC. Faecalibacterium, commonly reduced in UC, showed no significant difference. This first analysis of gut microbiota in Lebanese UC patients reveals a distinct microbial signature that partially diverges from global trends, supporting the need for region-specific microbiome studies and personalized microbiota-targeted therapies.
doi:10.1038/s41598-025-31435-x ↗ PMID 41398357 ↗ PMC12804816 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- Illumina MiSeq
- Age group
- adult
- Disease groups
- Non-IBD controls, Ulcerative colitis
- Anatomical sites
- —
Data availability
Specific data assets have not been resolved from the source yet — see the source repository below for the full file listing.
Strengths & limitations for reuse
Strengths
- Feature/OTU tables are advertised
- Taxonomic tables are advertised
- Participant-to-sample mapping is available
- Participant counts are documented
- Sample counts are documented
Limitations
- Not documented: raw reads are advertised
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.paired_end |
True |
Raw paired-end reads were first processed Section |
assay.platform |
Illumina MiSeq |
sequenced on the MiSeq® platform (Illumina, San Diego, CA, USA) Section |
assay.primers_reported |
True |
The primers included Illumina adapter overhang sequences: forward...and reverse... Section |
assay.read_depth_reported |
10000 |
samples were rarefied to an even sequencing depth of 10,000 reads per sample Section |
assay.sequencing_type |
amplicon_16s |
using 16S rRNA gene sequencing (V3–V4 region) Section |
assay.target_region |
V3–V4 |
We used amplicon sequencing of the 16 S rRNA V3–V4 region on fecal samples Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.age_group |
adult |
participants were eligible for inclusion if they were between 18 and 65 years of age Section |
cohort.disease_activity_metadata_available |
True |
The PRO2 score...was used to assess patient-reported disease activity... The endoscopic Mayo score...reflects mucosal appearance Section |
cohort.non_ibd_controls |
11 |
A total of 22 stool samples were collected, including 11 patients diagnosed with UC at AUBMC and 11 from healthy individuals. Section |
cohort.study_design |
cross_sectional |
Overall design: Cross-sectional, observational, case-control pilot study using 16S rRNA gene sequencing. Section |
cohort.total_participants |
22 |
Fecal samples from 11 UC patients and 11 healthy individuals were analyzed. Section |
cohort.treatment_exposure_documented |
True |
Immunosuppressants included biologic and systemic agents used for ulcerative colitis management Section |
cohort.treatment_response_metadata_available |
False inferred |
Clinical scores for stool frequency, rectal bleeding, and Mayo endoscopic activity were recorded only for UC patients Section |
cohort.ulcerative_colitis_participants |
11 |
A total of 22 stool samples were collected, including 11 patients diagnosed with UC at AUBMC and 11 from healthy individuals. Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.feature_or_otu_table |
True |
The resulting output consisted of a feature table of amplicon sequence variants (ASVs) Section |
data_assets.open_access |
True from source |
"isOpenAccess": "Y" Section |
data_assets.pipeline_or_tool_versions |
True |
Trimmed reads were then imported into QIIME2 (version 2025.4) Section |
data_assets.representative_sequences |
True |
The resulting output consisted of a feature table of amplicon sequence variants (ASVs) and their representative sequences. Section |
data_assets.taxonomic_table |
True |
Classification was performed...resulting in taxonomic labels spanning from phylum to species Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.body_site |
feces |
descriptorName: Feces Section |
specimens.inflamed_status_available |
True |
The endoscopic Mayo score...reflects mucosal appearance Section |
specimens.longitudinal_sampling |
False inferred |
Overall design: Cross-sectional, observational, case-control pilot study Section |
specimens.number_of_samples |
22 |
A total of 22 stool samples were collected Section |
specimens.participant_to_sample_mapping_available |
True |
Approximately 200 mg of stool was collected per participant Section |
specimens.sample_type |
stool |
A total of 22 stool samples were collected Section |